Navigation Links
Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
Date:7/9/2009

Company seeks partner to commercialize the technology

TORONTO, July 9 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (TSX:MBX) announced today that it has filed key patent applications based on its novel semen sexing discoveries and that it will now embark on the path to commercialization of this exciting technology.

Microbix' recent discoveries should provide a more cost-effective platform for semen sexing and significantly improve yields and quality of the sperm produced compared to the current commercial sexing technology.

Both are critical market factors that Microbix believes will allow the company to effectively penetrate and even expand the $3 billion Artificial Insemination (AI) market.

Semen sexing is instrumental to the dairy industry due to the growing international demand for female offspring and the negligible value of dairy bull calves.

"This market is attractive for its size and the absence of regulatory barriers, and importantly, our technology offers a predictable pathway through development to market," said William J. Gastle, C.E.O.

"Now that the intellectual property has been secured, we are focused on finding a strategic partner(s) to help realize Microbix' Semen Sexing Technology's (SST) significant commercial potential and we invite expressions of interest," said Mr. Gastle.

Microbix specializes in the development of biological technologies and commercializing them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Mississauga.

This press release contains forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements including the risks associated with failure to develop an
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
4. Microbix Announces A New Technology Platform For The SST Project
5. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
8. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
9. Arrow International Files and Mails Definitive Proxy Materials
10. VaxGen Files 2006 Financial Statements and Provides Cash Update
11. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...vember 30 Biopharmaceutical compan...ients have been enrolled in its,multinational regi...s,designed to show reduction in transplant related...eneic stem cell transplantation with a mismatched,...ligible for an allogeneic,stem cell transplantatio...
(Date:11/30/2009).... 30 BioMarin Pharmaceut...e Food and Drug Administration (FDA) has granted o...4-DAP), amifampridine phosphate, for the rare auto...LEMS). 3,4-DAP has previously received orphan dru...the Committee for Medicinal Products for Human Use...
(Date:11/30/2009)... Nov. 30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYS..., and medical-device research and,development outs...nited States,announced that it had been selected ... for the fifth consecutive year. The list recogniz...hnology, media, and telecommunications,industries ...
(Date:11/28/2009)...Vanuatu National Advisory Committee on Climate Cha...ion (SNC) Project in collaboration with the Vanuat...New Zealand have generated preliminary climate cha...background for the country’s SNC reporting t...te Change (UNFCCC). , Po...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4
... Tutogen Medical, Inc.,(Amex: TTG ), a leading ma...made from human (allograft) and animal (xenograft)... fiscal year and fourth quarter ended September,30...cal year include:, -- Total fiscal year 2007 rev... increased 38% in fiscal year 2007; -- Sales of ...
...s next-generation sequencing with latest microarra...LBERG, Germany, and LA JOLLA, Calif., Dec. 10 ,Par...new Genome-to-Array,Service. This Service gives sc...how in sequencing and microarrays even for DNA whe...is service, scientists can go from,biological gene...
...olio of Technologies for Enabling Faster, Easier,Q...al Medicine and Adaptive ...ion Biomarkers Inc (DBI),a leading developer of pr...l research and development, today announced the co... States Patent 7,297,497 by the,U.S. Patent and Tr...
Other Biology Technology:Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 2Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 3Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 4Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 5Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 6Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 7Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 8Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 9Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results 10New Microbial Genome-to-Array Service 2Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry 2
(Date:11/26/2009)...rried out in eight European countries has shown th...isease pandemic could have a significant role in r...in the open access journal BMC Infectious Disease...days and weekends/holidays, finding that they were...m Hasselt and Antwerp University, Belgium, led a t...
(Date:11/25/2009)...hormone produced in the stomach, may be used to bo...kinson,s disease, Yale School of Medicine research...of the Journal of Neuroscience . , Parkinson,s ...urons in an area of the midbrain known as the subs...oduction. Reduced production of dopamine in late-...
(Date:11/25/2009)...urse of a lifetime, the heart pumps some 250 milli...to do this, the muscle fibers of the heart have to...y Dr. Wolfgang Rottbauer, vice chair of the Depart...ital (Chairman: Prof. Dr. H. A. Katus), has discov...ty of the smallest muscular unit, the sarcomere. I...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2New genetic cause of cardiac failure discovered 2CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 1CRH Medical introduces non surgical hemorroid removal to Gastroenterology Fellowship program 50312 2No More Drama With TOMA LECHE 50310 1No More Drama With TOMA LECHE 50310 2No More Drama With TOMA LECHE 50310 3No More Drama With TOMA LECHE 50310 4Maybe Men Arent So Picky After All 50309 1Maybe Men Arent So Picky After All 50309 2
...As the specter of a worldwide outbreak of avian or...at new drugs are desperately needed since some str...e to the current roster of anti-flu remedies. , N...elp of resources at the San Diego Supercomputer Ce...more than two dozen promising and novel compounds ...
...esearchers at North Carolina State University have...e the skin if there is an abrasion, providing insi...re workers or individuals involved in the manufact...al biomedical applications of the tiny nanoparticl... different sizes, shapes and surface coatings do n...
...This release is available in German . , Metabolo...olecules of a cell or a tissue. The exponents of b...work of a pre-clinical metabolomics study in healt...the animals was treated with the diabetes drug Roz... quantitatively determined in a blood plasma sampl...
Other Biology News:UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 2UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 3UC San Diego researchers identify potential new drug candidates to combat 'bird flu' 4Study shows quantum dots can penetrate skin through minor abrasions 2Healthy or diseased? 2
... : GeneTraffic is built to be a straightforward, i...neTraffic provides visual and computational tools ...is. , Data and Project Management : Quickly ...rmation About a Microarray Experiment) standard. L...
Rat siTrio from B-Bridge International
Rat siTrio from B-Bridge International
Human siTrio from B-Bridge International
Biology Products: